Overall, it appears that PALB2 mutations are responsible for 1% to 2% of strongly familial breast cancer, but in Finland (and possibly in other founder populations), PALB2 mutations may account for up to 1% of all breast cancer. Here, PALB2 is linked to breast cancer.